Item 7.01 Regulation FD Disclosure.

On August 1, 2022, Entera Bio Ltd., a company organized under the laws of the State of Israel (the "Company", "we", "us", or "our") made available an updated corporate presentation. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at https://investors.enterabio.com.

Use of our Website and Social Media to Distribute Material Company Information

We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the "Investors" section of www.enterabio.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the "Investors" section of our website for important and time-critical information.

The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.



Item 9.01 Exhibits

(d) Exhibits.

Exhibit
Number     Exhibit
  99.1       Entera Corporate Presentation August 2022
104        Cover Page Interactive Data File.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses